Allocryptopine
From DrugPedia: A Wikipedia for Drug discovery
Allocryptopine
| |
Systematic (IUPAC) name | |
N/A | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C21H23NO5 |
Mol. mass | 369.41102 |
SMILES | & |
Physical data | |
Melt. point | 160.5 °C |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Contents |
Description
Allocryptopine has been isolated from opium in approximatety 0.01 per cent yietd as the -form. The alkaloid has been identified by NMR and mass spectrometry and by comparison of its infrared spectrum with that of its allotropic modification, -allocryptopine.it induces muscle contraction and relaxation in urinary bladder and ileum, respectively.Crystals of α- and β-allocryptopine were studied by X-ray diffraction analysis and have been found to be crystal modifications of allocryptopine.
Synthesis
(S)-n-methylcanadine + NADPH + O2 = allocryptopine + NADP+ + H2O
General Properties
*Molecular Weight
369.41102
*Molecular Formula
C21H23NO5
*IUPAC NAME
N/A
*Canonical Smiles
CN1CCC2=CC3=C(C=C2C(=O)CC4=C(C1)C(=C(C=C4)OC)OC)OCO3
*Isomeric Smiles
N/A
*XLogP
2.3
*Topological Polar Surface Area
57.2
IC50
37 ± 8 µM
Function
oxytocic agent